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Body fluid identification plays an important role in understanding how the events 
during a crime may have taken place.  The presence of a body fluid may help identify an 
individual who committed a crime, while the type of body fluid present may help 
investigators determine how a crime occurred.  Current body fluid identification 
techniques are not always conclusive and may only suggest the presence of a body fluid 
type.  A protocol developed by the New York City Office of the Chief Medical Examiner 
(OCME) established a method that confirms body fluid type through mass spectrometry.  
To identify marker proteins in a body fluid sample, the proteins in the sample must be 
digested into their smaller peptide fragments.  Currently, this digestion is performed with 
trypsin in an overnight process that takes at least eight hours to complete.  Microwave 
radiation has been shown to assist in the digestion of the body fluid protein samples, and 
the time needed for digestion reduced from eight hours to just minutes.  The effects of 
microwave radiation on the digestion of protein samples commonly found in body fluids 
were examined here and compared to traditional methods.  Ideal microwave assisted 
temperature of protein samples was determined to be 37°C, however no significant 
differences were observed between microwave assisted digestion and the traditional 
methods of digestion at different incubation times.  Overall, this research shows 
microwave radiation can be used to assist protein digestion, achieving similar results to 








   The presence and proper identification of the body fluids obtained from a crime 
scene may be a pivotal piece of evidence assisting in forensic investigations.  
Identification of a body fluid type at a crime scene plays an important role in defining 
future testing of a sample and, ultimately, may influence the outcome of a case (Virkler 
& Lednev, 2009).  Many types of body fluids may be found at a given crime scene.  
Blood, semen and saliva are the three most common body fluids found at a crime scene, 
however menstrual blood, vaginal fluid, sweat and urine are found as well, and may play 
an important role in the investigation (Harbison & Fleming, 2016).  DNA typing from a 
body fluid sample is one of the common means in which the ‘who’ of a crime may be 
established. When performing DNA typing, however, the type of a body fluid present in a 
sample may be just as important in determining the ‘what’, ‘where’ and ‘how’ of the 
crime.  Proper identification of the body fluid samples will also play an important role in 
how this evidence will be processed further in the laboratory.  Proper sample 
identification saves time, money and ensures the preservation of a sample for potential 
future testing.   
Current analysis of body fluids involves two types of tests: presumptive and 
confirmatory.  Presumptive tests are highly sensitive in nature (high detectability) 
however they may not necessarily be specific for a substance (may cross react with 
different substances).  In some cases, presumptive tests may result in a false positive, 
which by most standards is acceptable as long as no false negatives are obtained (Houck 
& Siegel, 2006).  Contrary to presumptive, confirmatory tests typically involve tests that 






the test may not be as sensitive (requiring a larger amount of the substance to test).  After 
presumptive tests are performed, positive results for the substance in question will 
typically lead to a confirmatory test.  Confirmatory tests may produce false negatives, but 
should not produce any false positives (Houck & Siegel, 2006).  The current process of 
presumptive and confirmatory tests is important in directing the flow of an investigation.  
Presumptive tests tend to offer a quick screening method to locate “invisible” or 
extremely small stains which may not be visible to the naked eye, as well as rule out 
stains which may appear to be similar to body fluids but are in fact not (Carr, 2009).  
Confirmatory tests on the other hand may be more time consuming, have higher 
laboratory costs and may require more assessment by the analyst, i.e. microscopic 
examination, DNA analysis or immunological testing.   
Blood is one of the most common types of body fluids that may be found at a 
crime scene; most methods of analysis and testing for body fluids, therefore, revolve 
around blood.  Presumptive tests for blood rely on the detection of hemoglobin 
molecules.  Colorimetric assays such as phenolphthalein and leucomalachite green use a 
colorless dye that once exposed to heme will cause a chemical reaction and change color 
to a pink or bluish green (Li, 2015).  Similar to colorimetric tests, chemiluminescent tests 
such as luminol test, will emit a fluorescent light when exposed to hemoglobin (Butler, 
2005).  Each of these tests is important for the screening and possible indication of blood 
at a crime scene, however they are capable of cross reacting with other chemicals or 
materials, potentially resulting in a false positive outcome (Carr, 2009).  Confirmatory 
tests need to be performed if blood presence is suspected.  These tests involve crystal 






2006).  The Takayama crystal assay (hemochromogen test) uses pyridine under alkaline 
conditions with a reducing sugar added to a presumed sample of blood on a microscope 
slide.  Heat is applied, and, if crystal formation is observed by means of a microscope, 
then the presence of blood is confirmed (Houck & Siegel, 2006).  Similarly, the 
Teichmann crystal assay (Hematin crystal assay) uses the application of acetic acid and 
salts introduced to a presumed blood sample.  The sample is then heated, and if crystals 
are observed under a microscope, the presence of blood is confirmed (Li, 2015).  Non-
destructive tests for blood are used when the sample is limited, and may be performed by 
attempting to extract DNA from the presumed blood sample for DNA analysis.  
However, if the sample was not blood, DNA would not be extracted and positive results 
would not be obtained.  
 Similar to the testing performed for the indication of blood, colorimetric and 
microscopic examinations may be used for presumptive and confirmatory testing when 
testing potential body fluid stains for semen.  Semen specimens contain high levels of 
acid phosphatase.  While the acid phosphatase enzyme does appear in semen, it is also 
present in nature (Houck & Siegel, 2006).  The Brentamine Fast Blue B test is a common 
presumptive test employed in semen detection.  A purple color formation that follows the 
introduction of sodium alpha naphthylphosphate and Fast Blue B solution will indicate 
the possible presence of semen (Butler, 2010).  To confirm the presence of semen, two 
common tests may be performed: direct observation of sperm cells using ‘Christmas 
Tree’ staining or prostate specific antigen (PSA)/p30 tests. Direct observation of sperm 
cells involves fixing recovered sperm cells on a slide using heat.  The cells are then 






fast red, picric acid and indigo carmine).  This staining results in red sperm heads, blue 
mid pieces of the sperm cells, and yellow-green color tails (Butler, 2012).  Forensic 
laboratories use observation of the sperm cells under a microscope to confirm the 
presence of semen.  Multiple tests may be performed to detect the presence of the 
PSA/p30 antigen.  This antigen is produced in the prostate and secreted into the seminal 
fluid.  Immunochromatic test kits, similar to home-pregnancy kits or enzyme-linked 
immunosorbent assays (ELISA), allow PSA detection (Li, 2015). 
The presence of saliva tends to be more difficult to detect in body fluid samples.  
Current testing procedures only allow for a presumptive test of saliva; no confirmatory 
test is generally used.  Presumptive tests for saliva involve testing for amylase.  Two 
common methods to test for amylase in a sample include the Phadebas test and the starch 
iodine radical diffusion test (Butler, 2005).  The Phadebas test uses a portion of sample 
where saliva is believed to be present (cutting of cloth, swab, etc.) incubated with the 
Phadebas reagent.  Amylase reacts with the reagent producing a blue color, indicating the 
presence of amylase (Li, 2015).  The starch iodine test uses an agar gel containing starch.  
The sample is placed in a well of the gel, and, if amylase is present, it will diffuse into the 
gel, hydrolyzing the starch.  The gel is then stained with iodine; clear area in the gel is 
indicative of the amylase presence (Li, 2015).  While each of these tests may confirm the 
presence of amylase, amylase itself may be present in other body fluids than saliva, and, 
therefore, these tests will not confirm the presence of saliva (Houck & Siegel, 2006). 
Presumptive and confirmatory tests for blood, semen and saliva require different 
techniques, different platforms on which to run, and different running times.  This creates 






DNA analysis.  Furthermore, the methods described may be destructive to the sample, 
and if a limited amount of a sample is present, these tests would not be advised in order 
to preserve the sample.  
Testing of samples believed to be vaginal fluid or menstrual blood is even more 
limited, and requires the use of sample collection and transport to a laboratory.  In these 
instances, testing of these samples requires microscopic examination or preparation for 
immunological assays.  These processes are time consuming, labor intensive, costly and 
require additional assessment by a trained analyst.   
Currently, body fluid tests to indicate vaginal fluid only provide presumptive 
results indicating a possible presence.  Staining and observation of cells under a 
microscope, identification of vaginal acid phosphatase and identification of possible 
vaginal bacteria, all work as presumptive tests to indicate the presence of vaginal fluid.  
Three cell staining methods: Lugol’s Iodine staining, Periodic Acid-Schiff staining and 
Dane’s staining involve introduction of chemical reagents to vaginal epithelial cells fixed 
to a microscope slide.  Lugol’s will react with glycogenated vaginal epithelial cells to 
form a dark brown glycogen-iodine complex, while the periodic acid-Schiff method will 
turn the cytoplasm of vaginal epithelial cells magenta and the nucleus purple.  The 
Dane’s staining method may provide more specificity by staining skin, buccal and 
vaginal epithelial cells different colors; red-orange for skin, orange-pink with red nuclei 
for buccal and bright orange with orange nuclei for vaginal cells (Li, 2015).  Microscopic 
observation of the color change in cells is required.  Unfortunately, Lugol’s and the acid-
Schiff methods cannot distinguish between vaginal epithelial cells and other 






produce results, therefore false positives or false negatives may occur.  Identification of 
acid phosphatase may also be important; however, it is necessary to determine if the acid 
phosphatase is vaginal or from the prostate due to semen exposure.  Vaginal acid 
phosphatase (VAP) and prostate acid phosphatase (PAP) are isozymes (enzymes with 
similar activities found in different tissues).  Agarose gel electrophoresis separates the 
two isozymes based on differing electrophoretic mobilities (Li, 2015).  The PAP will 
travel farther in the gel than the VAP, allowing for vaginal acid phosphatase presence to 
be determined.  Lastly, testing for bacteria commonly found in vaginal fluid may indicate 
its presence.  Lactobacillus bacteria are commonly found in the vagina and vaginal 
secretions.  Testing for multiple Lactobacillus taxa presence may indicate vaginal fluid 
however this genus has been seen in semen and female urine so it is not confirmatory (Li, 
2015).     
Detection of menstrual blood involves the identification of potential degradation 
products created during menstruation or enzyme concentrations in the blood.  During 
menstruation, plasmin cleaves fibrin, known as fibrinolysis, which inhibits the formation 
of blood clots.  When this occurs, degradation products are formed, specifically D-dimer 
which may be detected through enzyme-linked immunosorbent assays (ELISA) or 
immunochromatographic assays.  Since fibrinolysis occurs during menstruation, these D-
dimer assays may positively identify menstrual blood, however D-dimer has also been 
found in postmortem blood which, depending on the crime scene, may complicate results 
(Li, 2015).  Lactate dehydrogenase (LDH) is a common enzyme within the body used 
during the process of glycolysis.  In blood, five different isoenzymes of LDH; LDH1, 






being separated by their electrophoretic mobility.  LDH1, LDH2 and LDH 3 are more 
predominantly found in peripheral blood while LDH 4 and LDH 5 are more predominant 
in menstrual blood.  When blood samples are run on an agarose gel and the enzymes are 
separated, the predominant bands may indicate the type of blood from which the sample 
came (Li, 2015). 
Much research is currently underway to improve upon body fluid identification 
methods.  Many of these current methods involve the analysis of nucleic acids in the 
sample for identification.  Messenger RNA (mRNA) expression profiling involves the 
identification of mRNA markers that may be used to identify specific body fluids.  
mRNA carries the genetic information necessary to make proteins. Identifying specific 
mRNA markers for proteins specific to a body fluid type could help in the identification 
of that body fluid.  Another technique being studied is microRNA (miRNA) profiling.  
miRNA profiling involves the identification of specific miRNA markers that will be 
unique to a body fluid type.  miRNAs are used in the regulation of protein expression so 
identification of specific miRNA’s associated with proteins known to be expressed in a 
body fluid may lead to the identification of that body fluid.  Lastly, DNA methylation 
profiling looks at DNA methylation patterns that may be specific to a body fluid type.  
Different methylation patterns are tied to the expression of different proteins in body 
fluids so this pattern analysis may allow for identification of different body fluid types 
(summarized from Harbison & Fleming, 2016).   
While each of these techniques has the potential to identify specific body fluids, 
they all share some shortcomings.  DNA and to a further extent RNA are not the most 






Davidson, 2011).  Each of these testing methods requires the use of the polymerase chain 
reaction (PCR) that requires intact DNA or RNA strands in the region complementary to 
primers.  The primers are specific to the DNA or RNA sequence in the body fluid type 
(Hanson, Lubenow, & Ballantyne, 2009) Partial degradation of DNA or RNA could 
inhibit the PCR process, yielding incomplete results.  Establishment of these DNA or 
RNA assays requires some prior knowledge of the sample in order to determine what 
assay kit is required for analysis.  If the body fluid type is unknown, the correct assay kit 
may not be applied to the correct body fluid type, possibly resulting in inconclusive 
results.  Extra time would possibly be needed to perform presumptive, and/or 
confirmatory tests, prior to analysis.  DNA is limited to two copies in the nucleus of the 
cell, which limits the amount of total DNA that would be present in a sample.  This 
potential limit of DNA in the sample could affect how efficient the analysis is in 
determining sample type (Li, 2015).   
Protein analysis of body fluids by mass spectrometry may provide an alternative 
means of identification.  Mass spectrometry is used to identify unknown substances based 
on the mass of the ions released by the substance after it has been subjected to a 
bombardment of energy.  When the sample is exposed to the energy source, the sample 
becomes ionized, giving the sample a mass-to-charge (m/z) ratio.  This ratio is the mass 
of the sample over the number of charges on the ion.  The ions are then separated in the 
spectrometer based on this ratio.  When the sample reaches the end of the spectrometer, 
the m/z signal is measured based on the time taken to travel through the system and 
compared to the signal output.  The amino acid sequence of the sample protein is based 






sequence is then compared to a database of known references, and the protein can be 
identified (Skoog, Holler, & Crouch, 2007).   
There are several types of mass spectrometers used in laboratories and these vary 
based on the ionization system or separation system.  The matrix-assisted laser 
desorption-ionization (MALDI) system introduces the sample into the system evenly 
dispersed in a solid or liquid matrix.  The sample is placed on a metal plate and a laser 
beam is focused on the sample.  The matrix absorbs the energy from the laser and 
transfers the energy from the matrix to the sample.  The sample and matrix are then 
desorbed and ionized, releasing an ion plume of both the matrix and the sample.  The ion 
plume then travels through the analyzer and the spectrum is generated.  The typical 
separation system used with MALDI ionization is the time-of-flight (TOF) mass 
analyzer.  In these types of analyzers, the sample ions are separated by drift time.  After 
the sample is ionized the ions are accelerated through a drift tube, a low-pressure vacuum 
sealed tube, where the ions are separated based on mass.  The lighter particles travel 
faster through the tube and arrive at the detector before the heavier particles (Skoog, 
Holler, & Crouch, 2007).  The spectrum generated for the sample would then be the m/z 
ratio on the x-axis (related to the time of flight) and the intensity of the signal from the 
ion on the y-axis.    
 At the New York City Office of the Chief Medical Examiner (OCME) a 
confirmatory body fluid assay using mass spectrometry has been developed for blood, 
semen and saliva with testing that aims to expand and include menstrual blood and 
vaginal fluid.  This assay involves identification of functional proteins unique to each 






prepared and proteins are digested overnight into peptide fragments.  After the digestion 
the samples are plated on a mass spectrometer and the peptides present in the sample are 
identified.  The identified peptides are then compared to the peptides of known protein 
markers and are used to confirm that protein’s presence.  Identification of multiple body 
fluid marker proteins in the sample may confirm the presence of that body fluid type and 
the body fluid may be determined. 
Table 1. Components of body fluids used for potential body fluid identification.  
Compiled from Virkler & Lednev, 2009, Houck & Siegel, 2006 and Li, 2015.
 
 
 While the MS assay does present many potential benefits to test for multiple body 
fluid types through a single method, there are some steps in the method which may be 
improved, thus increasing sensitivity, efficiency and speed.  Menstrual blood, vaginal 
fluid and other body fluid mixtures are complex samples that need to be further evaluated 
to determine better purification steps needed to separate protein markers.  Increasing the 
sensitivity of the assay will allow for more complex samples to be identified with 
confidence through this method.  No two cases will provide the same amount of sample, 
therefore sample consumption is an issue when performing any test.  Evaluating 
extraction procedures to have the ability to co-extract protein and DNA samples 
simultaneously may save time, money and the limited sample.  A co-extraction process 
Blood Saliva Semen Vaginal Fluid Menstrual Blood
Hemoglobin Amylase Acid phosphatase Acid phosphatase Blood
Fibrinogen Lysozyme Prostate-specific antigen Lactic acid Functionalis tissue
Erythrocytes Mucin Spermatozoa Citric acid Mucus
Albumin Buccal epithelial cells Choline Urea D-dimer  (degradation product)
Glucose Thiocyanate Spermine Vaginal peptidase Lactate dehydrogenase
Immunoglobulins Potassium Semenogelin Glycogenated epithelial cells
Leukocytes Bicarbonate Zinc Acetic acid
Thrombocytes Phosphorus Citric acid Pyridine










may allow for samples to be prepared for DNA analysis, while the body fluid assay 
confirms the type of sample being processed.  This enables a lab to more efficiently 
process the sample.  Lastly, the speed with which a sample is able to be processed is 
important to prevent any delay in reporting.  Current preparation of samples for protein 
mass spectrometry involves the digestion of sample proteins overnight with trypsin.  
Decreasing the digestion time of samples may increase significantly the speed with which 
samples are processed, as well as the quantity of samples that may be processed 
simultaneously. 
 Since the mid 1980’s microwave radiation has been used in organic and inorganic 
chemistry as a tool to catalyze reactions.  The use of microwaves provides shorter 
reaction times, increase yields, and provides a cleaner synthesis by reducing the by-
product of reaction.  Since that time the microwaves have proven useful in multiple areas 
of science.  The mechanism behind how microwaves aid reactions is still not understood 
entirely, whether it is purely thermal (heat) based or if it is a combination of thermal and 
non-thermal energies.  In mass spectrometry proteomic studies, protein digestion is used 
to break down proteins into smaller peptide fragments for analysis.  The two approaches 
for this analysis are “top down” or “bottom up”.  The “top down” approach involves 
fragmentation of the intact protein sample in a mass analyzer with no previous protein 
digestion.  The more common “bottom up” approach digests proteins with a proteolytic 
enzyme, followed by mass spectrometry analysis.  When using the “bottom up” 
approach, samples are typically incubated overnight for enzymatic protein digestion.  The 






that the addition of microwave radiation may accelerate proteolysis, sometimes within the 
first few minutes of incubation (summarized from Lill, 2009).     
 This study investigates the use of microwave technology in decreasing the 
digestion time of samples and increasing the speed with which samples may be 
processed.  Studies and research have shown that the use of microwaves may not only 
significantly reduce the digestion time of proteins, but also may improve quality in the 
analysis of the proteins downstream.  Testing of the microwave digestion will be 
performed using the current MS protein assay being used.  Microwave digestion will be 
compared to standard overnight digestion currently in use and assessed for its ability to 
reach a complete digestion in a significantly reduced amount of time.  Multiple times, 
temperatures and power outputs of the microwave will be compared to determine the 
ideal microwave specifications to process the samples.  The results obtained from this 
study show that microwave radiation can be used to aid in protein digestion of protein 
markers used in the identification of body fluids, achieving similar results to traditional 








Current research in the identification of body fluids is focused on confirmatory 
testing through messenger RNA, microRNA, DNA methylation and mass spectrometry.  
Each of these testing methods focuses on the ability to create an ideal assay that would be 
able to identify multiple types of body fluids on a single platform.  The desire would be 
to have an assay that is accurate, reproducible, fast, sensitive, cost efficient and specific 
enough to accurately confirm the type of body fluid present.  The review below focuses 
on different types of nucleic acid body fluid identification methods currently being tested 
as well as the mass spectrometry method created by the New York City OCME.  
Optimization of the mass spectrometry method is also discussed, specifically the use of 
microwaves in the assistance of protein digestion.   
Messenger RNA (mRNA) is unique to a cell type, so profiling for specific mRNA 
allows analysts to test for mRNAs that may be specific to a body fluid (Butler, 2012).  
Research has shown the ability to create a multiplex RT-PCR assay for specific body 
fluid genes (Juusola & Ballantyne, 2005).  Juusola and Ballantyne presented an assay 
specific for eight different body fluids and optimized for blood, saliva, semen and vaginal 
secretions.  Using the same markers as Juusola and Ballantyne, Haas et al. (2008) found 
that testing on samples up to 15 months old were still able to produce positive results for 
the different blood types.  Research has been conducted on other mRNA markers for the 
same body fluids types, and similar results for identification were obtained (Nussbaumer, 
Gharehbaghi-Schnell, & Korschineck, 2006).  PCR is required in mRNA assays, so 
issues pertaining to small amounts of sample or sample degradation may inhibit 






(RNases) are also abundant and common to many environments, likewise leading to the 
degradation of a sample (Wu & Brewer, 2012).   
To overcome possible issues stemming from sample degradation, microRNAs 
(miRNAs) have been explored as suitable alternatives.  MicroRNAs may be up to ten 
times smaller than mRNAs, making them potentially a better option, if degradation is 
expected (Zubakov, Boersma, & Choi, 2010).  Jung et al. (2010) found that miRNAs 
showed better stability than mRNAs in samples where RNA concentration was at least 
100 ng/µl.  Additionally, it was found that some assays were able to produce positive 
results with as little as 50 picograms of total RNA present (Hanson, Lubenow, & 
Ballantyne, 2009).  The miRNA expression profile for each body fluid obtained by 
Hanson et al. was found to be highly specific, and differentiated from the miRNA 
expression profiles of 21 other human tissue types.  miRNA profiling requires a pattern 
of multiple expressed miRNAs for a body fluid type, rather than a single expressed 
miRNA (Hanson, Lubenow, & Ballantyne, 2009).  For this reason, miRNA studies 
typically involve reverse transcription PCR (RT-PCR) and microarray analysis.  Zubakov 
et al. (2010) was able to confirm miRNA markers with both RT-PCR and microarray 
analysis for blood and semen; however, the researchers could not confirm microarray 
results of saliva, menstrual blood, or vaginal secretions with RT-PCR.  Along with the 
multiple assay steps, miRNA profiling requires much care and attention to detail.  While 
miRNAs tend to show more stability than mRNA, some studies still question the overall 
stability of miRNA over time.  Bravo et al. (2007) found that samples that were isolated 
using a common miRNA kit and stored at -80°C were highly unstable.  Further research 






play a significant role in the stability of miRNA samples (Mraz, Malinova, Mayer, & 
Pospisilova, 2009).     
DNA is known to be a more stable molecule than RNA, therefore DNA based 
assay methods may be more beneficial in identifying body fluid than RNA based 
methods.  DNA methylation occurs naturally in the human genome; it inhibits gene 
expression by affecting chromatin structure (Hashimshony, Zhang, Keshet, Bustin, & 
Cedar, 2003).  Further, different DNA methylation patterns were found in different 
tissues (Li, 2015).  These different methylation patterns, tissue-specific differentially 
methylated regions (tDMRs), show that body fluids may be distinguished based on these 
patterns (An, Choi, Shin, Yang, & Lee, 2013).  Frumkin et al. (2011) tested 50 different 
samples from blood, semen, saliva and skin and was able to differentiate between them 
all.  They were further able to demonstrate the identification of semen and saliva 
mixtures at different ratios.  Other advantages to this technique include the potential to be 
easily integrated to existing DNA analysis methods, does not require separate extractions, 
and DNA tends to be more stable than RNA (Grskovic, Zrnec, Vickovic, Popovic, & 
Mrsic, 2013).  While DNA molecules have these advantages, degradation of DNA can 
still hinder some of the testing.  Age, gender and ethnicity may affect methylation 
patterns, and multiple primers would likely still be required to identify different 
methylation patters. 
Protein analysis of body fluids by mass spectrometry provides an alternative 
means for identification of body fluids.  Mass spectrometry works by identifying 
molecules based on their mass.  Samples are ionized through a number of different 






spectrometer, a signal is recorded and corelated to a specific molecule.  These signals are 
compared to known databases, and the molecule being tested may be identified.  
Combining a mass spectrometer with liquid chromatography (LC) is beneficial to an 
assay since it provides an extra separation step for complex samples (Skoog, Holler, & 
Crouch, 2007).  In protein mass spectrometry, the LC step helps separate out the peptides 
in protein samples after digestion and prior to ionization.  Coupling the LC system with a 
tandem mass spectrometry system (MS/MS) provides even greater resolution when 
identifying peptides in a complex protein sample.   In MS/MS systems after the sample is 
ionized, it enters a collision chamber where the sample is fragmented.  The mass of the 
fragments is analyzed, and the parent component is confirmed based on the fragment 
masses (Siegel, 2012).  Yang et al. (2012) tested five separate methods for the 
identification of proteins in menstrual blood.  Across all five methods, a total of 1061 
menstrual blood proteins were identified.  Of those 1061 proteins, 385 were found to be 
unique to menstrual blood, while the remaining proteins were shared with venous blood 
or vaginal fluid.  Each of these methods utilized LC-MALDI TOF/TOF mass 
spectrometry for peptide identification.  In 2012, a proposal by Dr. Donald Siegel of the 
New York City OCME was awarded grant funding from the National Institute of Justice 
to further study body fluid protein markers, and establish an assay based on mass 
spectrometry.  Early results for the mass spectrometry assay were published in 2013 by 
Yang et al.  In this method, digestion of marker protein present in a body fluid sample 
resulted in the different peptide fragments that made up that protein.  Tandem mass 
spectrometry (MS/MS) analysis allows for the identification of the specific peptides by 






mass fingerprinting - a high throughput method of peptide identification through mass 
spectrometry (Henzel, Watanabe, & Stults, 2003).  Identification of the peptides is useful 
in identifying the presence of a marker protein and the presence of multiple marker 
proteins, allowing for the identification of a body fluid.  Since mass spectrometry would 
identify whatever peptides are present in the sample, prior knowledge of the type of 
sample is not necessary.  Yang et al. (2013) were able to identify distinct proteins in each 
body fluid type: 59 in blood, 48 in semen and 77 in saliva.  The number of distinct 
peptides that were identified for each body fluid type was 954, 1246 and 922 
respectively.  Protein markers for each body fluid were selected based on how 
unique/enriched the protein was in each body fluid and how abundant the protein was in 
the body fluid.  This research identified four candidate markers for blood, five for saliva 
and eight for semen (Yang, Zhou, Deng, Prinz, & Siegel, 2013).   
According to Yang et al. (2013), assay liquid samples were prepared by adding 10 
volumes of radioimmunoprecipitation assay (RIPA) buffer to the sample.  Samples were 
homogenized and spun down.  Protein concentration of sample supernatant was measured 
using the Bradford Protein assay.  Thirty micrograms of total protein were then digested 
overnight at 37°C with trypsin in a 20:1 protein to trypsin ratio.  Digested peptides from 
the samples were separated using high performance liquid chromatography (HPLC).  
After the HPLC separation, samples were spotted on a metal plate, and MALDI 
TOF/TOF mass spectrometry was performed.  Based on the MS/MS sequence obtained, 
sample peptides were identified by comparison of the sequence to a database. 
One of the draw backs for protein mass spectrometry assays is the amount of time 






anywhere from several hours to overnight (Yu, Gilar, Lee, Bouvier, & Gebler, 2003). The 
ability to decrease the amount of time required for a trypsin digestion may reduce 
significantly the time required to complete a mass spectrometry assay for the 
identification of body fluids.  Organic solvents have been used to increase digestion 
efficiency and decrease incubation times.  Russell and Park (2001) found that addition of 
organic solvents increased the amount of digestion fragments recovered after a one-hour 
incubation at 37°C versus digestion in an aqueous solvent.  The digest fragments from the 
aqueous solvent system produced 58% coverage of the entire amino acid sequence in 
one-hour, whereas a 60% methanol solution, 40% acetone solution and 40% acetonitrile 
solution produced 66%, 79% and 72% coverage of the entire amino acid sequence 
respectively (Russell & Park, 2001).  Enhanced digestion by means of microwave 
radiation has been reported, and yielded significant reductions in digestion time.   
Pramanik et al. reported in 2012 the use of microwave radiation to aid tryptic 
digestion of bovine cytochrome c.  After ten minutes of microwave-assisted digestion, the 
authors found a large percentage of peptides that make up the protein by means of mass 
spectrometry.  Comparison of the microwave to a standard water bath found that a 
twelve-minute microwave-assisted digestion at 37°C was comparable to a six-hour 
digestion in a water bath at 37°C.  Other research has also shown that microwave-assisted 
tryptic digestion was much faster, and complete proteolysis could be achieved in one-
hour, as opposed to water-bath incubated digestion (Lill, Ingle, Liu, Pham, & Sandoval, 
2007).  Furthermore, research combining the idea of microwave-assisted digestion with 
the addition of organic solvents has also showed some promise.  Lin et al. (2005) found 






has the ability to accelerate the enzymatic digestion of some proteins, while decreasing 
the time required for digestion, as compared to standard water bath digestions.  Research 
has also found that in cases where immobilized enzyme is used, as opposed to free 
enzyme, more efficient digestion times were achieved with the use of microwave 
irradiation (Lin, et al., 2008, A).  Here, we examine the effect of microwave radiation in 








Material and Methods 
Sample Preparation  
Blood Samples 
All sample tubes were labeled with a sample name and date of preparation.  For 
samples of a known concentration, the concentration was also recorded on the sample 
tube.  Venous blood was collected previously and stored by the laboratory in a freezer.  
Blood samples were collected during previous research at the New York City OCME in 
accordance with approval from the IRB committee at the New York City Department of 
Health and Mental Hygiene, IRB 08-040.  The blood sample was assigned the unique 
identifier “271 Blood”.  One-milliliter aliquots from the stock container of 271 blood 
were maintained throughout the experiment in 1.5-mL microcentrifuge tubes and kept 
frozen.  A 1:10 dilution of blood sample was prepared in a 1.5-mL microcentrifuge tube, 
50 µl of blood sample in 450 µl of RIPA buffer (Boston Bioproducts Inc., Ashland, MA, 
USA).   
Hemoglobin Samples  
Lyophilized powdered human hemoglobin (Sigma Aldrich, St. Louis, MO, USA) 
was stored at 4°C.  In a 1.5-mL microcentrifuge tube a solution of hemoglobin was 
prepared by dissolving 0.004 g of powder in 1.0 mL RIPA buffer (Boston Bioproducts 
Inc., Ashland, MA, USA), yielding a final concentration of 4 µg/µl (wt/v ratio).  The 
diluted sample was stored at 4°C.   
 Human Serum Albumin Samples 
Human serum albumin powder (Sigma Aldrich, St. Louis, MO, USA) was stored 






prepared by dissolving 0.004 g of powder in 1.0 mL RIPA buffer (Boston Bioproducts 
Inc., Ashland, MA, USA), producing a final concentration of 4 µg/µl (wt/v ratio).  The 
diluted sample was stored at 4°C.      
Hemoglobin and Human Serum Albumin Mixture Samples 
A volume based one-to-one mixture of 4 µg/µl hemoglobin and 4 µg/µl human 
serum albumin was prepared as needed.   
Sample Homogenization 
All of the samples were homogenized using the FastPrep®-24 (MP Biomedicals, 
Irvine, CA, USA) instrument.  To each 1.0-mL microcentrifuge tube-containing sample, 
approximately one capful of lysing matrix D beads (MP Biomedicals, Irvine, CA, USA) 
was added.  The sample was then placed on the FastPrep®-24 (MP Biomedicals, Irvine, 
CA, USA) instrument, and vortexed at 6 m/s for 40 seconds.  Samples were spun in a 
5415 D centrifuge (Eppendorf, Hamburg, Germany) for 1 minute at 8,000 rpm.  The 
supernatant was transferred to a new 1.5-mL microcentrifuge tube.  In a 5810 R 
refrigerated centrifuge (Eppendorf, Hamburg, Germany) the homogenized samples were 
pelleted by spinning the samples at 18,000 rcf for 30 minutes at 4°C.  After the samples 
were spun, the supernatant was removed and transferred to a new appropriately labeled 
1.5-mL tube for processing.  The tube was labeled with a “S” for supernatant.  Only 
supernatant samples were used for down-stream processing.  One-hundred microliters of 
RIPA buffer was added to the tube containing the pellet, the tube was vortexed, and the 
pellet resuspended.  A “P” for pellet was added to the tube label, and the resuspended 








Bradford Protein Assay Determines Sample Protein Concentration  
For each sample type the Bradford Protein Assay was performed to determine 
sample protein concentration.  Blood supernatant samples were diluted 1:10 prior to 
quantitation; 10 µl of blood supernatant were combined with 90 µl of ddH2O.  A one-to-
one mixture of hemoglobin and human serum albumin was made.  Three-hundred 
microliters of hemoglobin supernatant were combined with 300 µl of human serum 
albumin supernatant for a total stock volume of 600 µl.  Bovine Serum Albumin (BSA) at 
a known concentration of 2.0 µg/µl was used as the standard for the assay.  A 0.5 µg/µl 
dilution of the standard was made by combining 10 µl 2.0 µg/µl BSA (Thermo Scientific, 
Waltham, MA, USA) in 30 µl of ddH2O.  Dilutions of the concentrated and diluted BSA 
were made in a plate to create a range of 0.0 µg/µl to 1.4 µg/µl of the standard.   Each of 
the standard and sample wells received 250 µl of Bradford reagent.  The Bradford reagent 
(Coomassie Brilliant Blue) binds to sample protein.  As protein concentration increases 
the amount of dye bound to the protein increases.  Table 2 below shows the concentration 
and volumes used for the standards and samples for the assay.  Each standard or sample 







Table 2.  Volumes and concentrations of standards and samples used for the Bradford 
Protein Assay.  The Bovine Serum Albumin (BSA) standard was run at a range of 0.0 µg 
to 7.0 µg.  Standards and samples were diluted in ddH2O.  Bradford reagent used for all 












Reagent Volume (µl) 
0.0 - - 5.0 - 250.0 
0.5 
1.0 µl =  
0.1 µg/µl - 4.0 - 250.0 
1.0 
2.0 µl =  
0.2 µg/µl - 3.0 - 250.0 
2.0 
4.0 µl =  
0.4 µg/µl - 1.0 - 250.0 
4.0 - 
2.0 µl =  
0.8 µg/µl 3.0 - 250.0 
6.0 - 
3.0 µl =  
1.2 µg/µl 2.0 - 250.0 
7.0 - 
3.5 µl =  
1.4 µg/µl 1.5 - 250.0 
- - - 5.0 - 250.0 
- - - 4.0 1.0 250.0 
- - - 3.0 2.0 250.0 
- - - 2.0 3.0 250.0 
- - - 1.0 4.0 250.0 








Figure 1. Typical plate set up of the Bradford Protein Assay.  The first two columns on 
the plate contained the standard run in duplicate.  Columns containing samples were 
paired in twos so the samples could be processed in duplicate.  Empty wells on the plate 
contained no sample or reagent. 
Once the plate was prepared, it was placed on the Synergy HT Multi-detection (Bio-Tek 
Instruments, Winooski, VT, USA) to measure the absorbance in each well.  Absorbance 
was tested at 595 nm, as that is the wavelength of maximum absorbance for Bradford 
reagent bound to protein.  The average absorbance values for duplicate wells were 
determined.  Absorption values were corrected to the 0.0 µg/µl standard concentration 
value.  For example, if the average net absorbance for the 0.0 µg/µl BSA standard was 
.470 then .470 was subtracted from the absorbance values of a known concentration.  
This subtracted absorbance value was then associated with the known standard 
concentration.  A standard curve was made in a Microsoft Excel spreadsheet comparing 
average absorbance values to known concentrations of the BSA standard.  The average 
absorbance value of each sample was compared to the standard curve to determine the 
concentration of the diluted samples.  This concentration was multiplied by the sample 
dilution factor to determine the actual concentration of the original sample.   
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Preparation of samples for protein digestion 
Acetone precipitation, reduction, and cysteine blocking was performed on each 
sample prior to protein digestion.  Samples were diluted to 1-4 µg/µl, using ddH2O, based 
on the quantitation from the Bradford protein assay.  For each digestion condition, 
sample tubes, positive controls and negative controls were prepared.  A separate tube was 
prepared as a comparison control for the traditional overnight digestion.  To each tube a 
total of 20 µg of sample protein was added.  Acetone was chilled to -20°C and samples 
were chilled to 4°C.  Six volumes of cold acetone were added to each sample and the 
control tube.  The tubes were inverted three times to ensure homogeneous mixing. 
Sample tubes were incubated between 30 minutes and 4 hours (typically 1 hour) at -20°C 
until a flocculent formed.  Sample tubes were centrifuged for 10 minutes at 6,000 rcf 
(Eppendorf, Hamburg, Germany) to pellet the flocculent.  Excess acetone was poured off, 
and the sample was partially dried at room temperature for 3-5 minutes.  After the 
acetone precipitation, 20 µl of 500 mM triethylammonium bicarbonate (TEAB) buffer 
from the iTRAQ labeling kit (SCIEX, Framingham, MA, USA) was added to resuspend 
the pelleted sample.  To conserve iTRAQ reagents when samples were not going to be 
tested on the LC/MS, 50mM ammonium bicarbonate (ABC) buffer and 50 mM TEAB 
buffer (diluted from iTRAQ reagents) were used to resuspend the pellet.  The digestion 
efficiency during microwave incubation was compared to the 500 mM TEAB buffer.  
The 50 mM ABC buffer was prepared by mixing 0.07906 g of ammonium bicarbonate 
(Fluka Analytical, St. Louis, MO, USA) in 1.0 mL of ddH2O for 1M ABC buffer.  In a 
new tube the buffer was diluted to 50 mM by adding 5 µl of 1M ABC buffer to 95 µl or 






TEAB buffer (SCIEX, Framingham, MA, USA) in 180 µl of ddH2O.  After the pellet was 
resuspended, 1 µl of denaturant (SCIEX, Framingham, MA, USA) and 2 µl of reducing 
reagent (SCIEX, Framingham, MA, USA) were added to each sample.  Sample tubes 
were vortexed, spun down, and incubated for 1-hour at 60°C.  Samples were quick spun 
to bring all liquid to the bottom of the tube then 1 µl of cysteine blocking reagent 
(SCIEX, Framingham, MA, USA) was added to each sample.  To conserve cysteine 
blocking reagent for samples not being run on the LC/MS, a solution of 500 mM 
iodoacetamide was prepared by combining 0.056 g iodoacetamide (Sigma-Aldrich, St. 
Louis, MO, USA) in 600 µl ddH2O.  Samples were vortexed and spun to bring all liquid 
to the bottom of the tube, then incubated for 10 minutes at room temperature.  At this 
stage, samples were now prepared for protein digestion. 
Traditional protein digestion with trypsin and incubator 
 A stock solution of 0.5 µg/µl trypsin was prepared by combining 100 µg of 
trypsin (Promega, Madison, USA) with 200 µl of trypsin resuspension buffer (Promega, 
Madison, WI, USA).  Sample tubes were placed on ice prior to trypsin addition to prevent 
the reaction from occurring before the samples were placed in a microwave or on an 
incubator.  To each sample, 2 µl of trypsin was added making the sample protein to 
trypsin ratio 20:1. Each positive control tube received 2 µl of trypsin; each negative 
control tube received 2 µl of ddH2O in place of trypsin.  Samples were vortexed and spun 
down, then placed on a tabletop incubator following traditional protein digestion methods 
to observe how digestion occurred over different temperatures and times for each sample.  
Digestion temperatures of 45°C, 55°C and 65°C were tested and compared to the 






minutes, 1 hour and 2 hours were compared to the overnight digestion.  After each 
digestion, phenylmethylsulfonyl fluoride (PMSF) was added to test its ability to inhibit 
trypsin activity and allow for better visibility of how each digestion condition worked.  A 
stock concentration of 100 mM PMSF was prepared by combining 0.017419 g of 
phenylmethylsulfonyl fluoride (Acros Organics, Geel, Belgium) with 1.0 mL methanol 
(Fisher Scientific, Waltham, MA, USA).    
Protein digestion with trypsin and microwave radiation 
A stock solution of 0.5 µg/µl trypsin was prepared by combining 100 µg of 
trypsin (Promega, Madison, WI, USA) with 200 µl of trypsin resuspension buffer 
(Promega, Madison, WI, USA).  Samples were placed on ice prior to trypsin addition to 
prevent the reaction from occurring before the samples were placed in a microwave or in 
an incubator.  To each sample 2 µl of trypsin were added, making the sample protein to 
trypsin ratio as 20:1. Each positive control tube received 2 µl of trypsin and each negative 
control tube received 2 µl of ddH2O in place of trypsin.  Samples were vortexed and spun 
down.  Negative controls were processed in a microwave with samples.  Positive controls 
were placed in a tabletop incubator at 37°C for the same amount of time as samples were 
run in a microwave.  A separate overnight tube was also placed inside the tabletop 
incubator at 37°C.  The microwave used for the experiment was the CEM MARS 6 
microwave reaction system (CEM, Matthews, USA).  This system allows for adjustment 
and regulation of power and temperature control as well as readings of power and 
temperature for accurate measurements.  Power settings and temperature directly affected 
microwave ramp time and run time.  Microwave power settings (watts) and temperature 






times.  Power settings were adjusted between 50 and 70 watts; temperature settings 
ranged from 37°C to 65°C.  An ideal power setting of 50 watts was determined to provide 
the most consistent ramp time for the varying range of temperatures.  Samples are placed 
in a hollow microcentrifuge tube container which holds 25 mL of water.  The water level 
in the container is below the bottom of the tubes so the water never touches the tubes 
during the microwave process.  The 25 mL water bath captures the microwave energy to 
maintain the temperature around the sample tubes.  A probe placed into a hole in the cap 
of a 1.5 mL microcentrifuge containing buffer continuously monitors the temperature.  
Based on the temperature recorded by the probe, microwave input is automatically 
adjusted to maintain the desired temperature.  Microwave incubation conditions were 
tested based on table 3 below.  Temperature conditions were tested first followed by run 
time.  Digestion times were based on the total time samples were in the microwave with 
the instrument running.  All runs started with an initial 3-minute ramp up to temperature 
followed by the remaining time held at that temperature.  For example, a 15-minute 
digestion would have a 3-minute ramp up to the desired temperature followed by a 12-
minute hold at the desired temperature.  Following each run, samples were placed on ice 
and phenylmethylsulfonyl fluoride (PMSF) was added to inhibit trypsin activity and 
allow for better visibility of how each digestion condition worked.  A stock concentration 
of 100 mM PMSF was prepared by combining 0.017419 g of phenylmethylsulfonyl 
fluoride (Acros Organics, Geel, Belgium) with 1.0 mL methanol (Fisher Scientific, 








Qualitative Analysis of Samples after traditional and microwave-assisted digestion 
A qualitative analysis of the samples was performed using microfluidic gel 
electrophoresis (MiGE) on the Agilent 2100 Bioanalyzer (Agilent Technologies, Santa 
Clara, CA, USA).  For analysis of blood, hemoglobin, human serum albumin and 
hemoglobin/human serum albumin mixture samples, the Agilent Protein 80 kit was used.  
Based on manufacturer specifications, the Agilent Protein 80 kit has a sizing range of 5-
80 kilo-Daltons (kDa) and is more sensitive for qualitative testing of samples 
concentrated between 0.006 – 4.000 µg/µl than other kits.  Samples were compared based 
on digestion patterns and intermediate digestion products. 
Table 3. Example of sample processing to determine ideal microwave digestion 
conditions.  Negative controls contained sample and all reagents except trypsin.  Positive 
controls were digested in an incubator to compare similar incubation times between the 
microwave and traditional method.  An overnight sample was digested in an incubator to 
compare the traditional overnight digestion method to the microwave.  PMSF was used to 












Negative Microwave 20 2.9 µl NA 
37 
0 time NA 20 2.9 µl 2.0 µl 
37 
Overnight Incubator Overnight 2.9 µl 2.0 µl 
37 
Sample 1 Microwave 20 2.9 µl 2.0 µl 
37 
Sample 2 Microwave 20 2.9 µl 2.0 µl 
37 










Bradford Protein Assay 
 Standard sample concentrations were prepared using the procedure described 
previously under the Sample Preparation heading found in the “Methods and Materials” 
section.  Sample concentrations were determined based on a comparison of absorbance 
compared to a known standard of bovine serum albumin (BSA).  Standards and unknown 
samples were processed in duplicate to determine the mean absorbance value.  Mean 
absorbance values were corrected to adjust the absorbance value to zero when the sample 
concentration was zero.  The zero-concentration absorbance was subtracted from the 
mean absorbance of each of the samples, and the net absorbance for each sample was 
determined.  The known concentrations of the BSA standard were compared to the net 
absorbance values to create a standard curve.  Net sample absorbance values were 
compared to the standard curve to determine protein concentration in each of the samples.   
271 Blood sample 
An initial blood sample was tested as a proof of concept and practice test for lab 
familiarization.  A standard curve equation was determined based on the known 
concentrations of the BSA standard, y = 0.2857x – 0.0121 where y is the net absorbance 
and x is the concentration. Net absorbance values for the five diluted samples were 
recorded.  Using the standard curve equation, concentrations of each diluted sample were 
determined.  Table 4 below shows the absorbance, net absorbance and concentration 







Table 4.  Absorbance, mean absorbance, net absorbance and concentration of known 
BSA standards and 271 blood sample.  
Bradford BSA Standard  Bradford 271 Blood Sample  
Conc. 











Conc. based on 
STD curve (µg/µl) 
y=0.2857x-0.0121 
0.0 0.471 0.470 0.471 0.000 0.000 0.469 0.468 0.469 0.000 - 
0.1 0.499 0.508 0.504 0.033 1.000 0.596 0.585 0.591 0.122 0.469 
0.2 0.529 0.517 0.523 0.053 2.000 0.744 0.727 0.736 0.267 0.977 
0.4 0.543 0.475 0.509 0.039 3.000 0.876 0.855 0.866 0.397 1.432 
0.8 0.731 0.696 0.714 0.243 4.000 0.961 0.962 0.962 0.493 1.768 
1.2 0.826 0.779 0.803 0.332 5.000 1.032 1.047 1.040 0.571 2.041 
1.4 0.866 0.850 0.858 0.388             
 
 
Figure 2.  Standard curve of known BSA standard concentrations to determine unknown 
concentrations of 271 blood sample.   
 
To estimate the whole blood sample concentration, known concentrations of diluted 
blood samples were multiplied by dilution factors.  Table 5 below shows the dilution 
factor of each sample run on the Bradford assay, the concentration of each sample after it 
was multiplied by its dilution factor and the average concentration of the original sample 
used for the Bradford assay.   
 




































Table 5.  Estimated concentration of 271 blood sample prior to Bradford Assay 
Diluted 271 Blood Supernatant Concentration 
Sample Vol. (µl) Conc. based on STD curve (µg/µl) Bradford Assay Dil. Factor Conc. Before Bradford 
1.000 0.469 5.000 2.347 
2.000 0.977 2.500 2.442 
3.000 1.432 1.667 2.387 
4.000 1.768 1.250 2.210 
5.000 2.041 1.000 2.041 
  Avg. Conc. 2.285 
 
The concentration of each sample was multiplied by its dilution factor from the assay and 
then the average concentration was determined.  The average concentration was 
multiplied by 100 to account for the two 10 X dilutions performed before the assay.  The 
final estimated concentration of blood sample 271 was 228.5 µg/µl. 
271-Blood and Hemoglobin-HSA mixture samples  
Samples of 271 Blood and Hemoglobin-HSA mixture were tested using the 
Bradford protein assay to determine the concentration of diluted blood samples and 
freshly mixed hemoglobin-HSA samples to be used for protein digestion testing.  
Samples were prepared as previously described under the Sample Preparation heading of 
the Methods and Materials section of this paper.  Blood samples were diluted 100 times 
while the fresh hemoglobin and HSA samples were made stock at approximately 4 µg/µl 
with hemoglobin human lyophilized powder and human serum albumin powder 
respectively.  Three-hundred microliters of stock hemoglobin and HSA were combined 
for a total of 600 µl of approximately 4.0 µg/µl hemoglobin-HSA mix.  A standard curve 
equation was determined based on the known concentrations of the BSA standard, y = 
0.3535x – 0.0316 where y is the net absorbance and x is the concentration. Net 






equation, concentrations of each sample were determined.  Tables 6, 7 and 8 below show 
the absorbance, net absorbance and concentration values for the BSA standard, diluted 
271 blood sample, and hemoglobin-HSA mix sample respectively. 




Table 7.  Absorbance, mean absorbance, net absorbance and concentration of 271 Blood 
sample. 
271 Blood Sample  
Sample Vol. (µl) Abs. 1 Abs. 2  Mean Abs. Net Abs. 
Conc. based on STD curve (µg/µl) 
y = 0.3535x – 0.0316 
0.000 0.403 0.407 0.405 0.000 - 
1.000 0.545 0.537 0.541 0.136 0.474 
2.000 0.704 0.689 0.697 0.292 0.914 
3.000 0.701 0.851 0.776 0.371 1.139 
4.000 0.926 0.916 0.921 0.516 1.549 
5.000 0.988 0.973 0.981 0.576 1.717 
 
Table 8.  Absorbance, mean absorbance, net absorbance and concentration of 
hemoglobin-HSA mixture sample. 
Hemoglobin-HSA Mixture Sample  
Sample Vol. (µl) Abs. 1 Abs. 2  Mean Abs. Net Abs. 
Conc. based on STD curve (µg/µl) 
y = 0.3535x – 0.0316 
0.000 0.395 0.408 0.402 0.000 - 
1.000 1.152 0.933 0.933 0.532 1.593 
2.000 0.986 0.998 0.992 0.591 1.760 
3.000 1.209 1.173 1.191 0.790 2.323 
4.000 1.301 1.345 1.323 0.922 2.696 
5.000 1.469 1.482 1.476 1.074 3.128 
 
BSA Standard  
Conc. (µg/µl) Abs. 1 Abs. 2 Mean Abs. Net Abs. 
0.0 0.399 0.395 0.397 0.000 
0.1 0.408 0.410 0.409 0.012 
0.2 0.432 0.424 0.428 0.031 
0.4 0.474 0.463 0.469 0.072 
0.8 0.647 0.629 0.638 0.241 
1.2 0.819 0.750 0.785 0.388 






In table 8, the absorbance value recorded for the first absorbance for sample volume 1.0 
of the hemoglobin-HSA mixture was not used for the mean absorbance value or net 
absorbance value.  This value was believed to be an outlier and had no significant effect 
on the actual undiluted sample concentration.  Figure 3 shows the standard curve used to 
determine the concentration of each sample.   
 
Figure 3.  Standard curve of known BSA standard concentrations to determine unknown 
concentrations of 271 blood sample and hemoglobin-HSA mixture sample.   
 
During testing a second stock of the hemoglobin-HSA mixture sample was prepared.  
This stock was prepared as described above and tables 9 and 10 show the absorbance, net 
absorbance and concentration values for the BSA standard and second hemoglobin-HSA 
mix sample.  Figure 4 shows the standard curve used to determine the concentrations.   
 


































Table 9.  Absorbance, mean absorbance, net absorbance and concentration of known 
BSA standards. 
BSA Standard  
Conc. (µg/µl) Abs. 1 Abs. 2 Mean Abs. Net Abs. 
0.0 0.487 0.484 0.486 0.000 
0.1 0.514 0.514 0.514 0.029 
0.2 0.536 0.533 0.5345 0.049 
0.4 0.569 0.601 0.585 0.100 
0.8 0.710 0.725 0.718 0.232 
1.2 0.821 0.801 0.811 0.326 
1.4 0.870 0.903 0.8865 0.401 
 
Table 10.  Absorbance, mean absorbance, net absorbance and concentration of 
hemoglobin-HSA mixture sample. 
Hemoglobin-HSA Mix Sample  
Sample Vol.(µl) Abs. 1 Abs. 2  Mean Abs. Net Abs. 
Conc. based on STD curve (µg/µl) 
y=0.284x-0.0041 
0.000 0.490 0.490 0.490 0.000 - 
1.000 0.642 0.650 0.646 0.156 0.564 
2.000 0.769 0.734 0.752 0.262 0.935 
3.000 0.866 0.861 0.864 0.374 1.330 
4.000 0.948 0.991 0.970 0.480 1.703 
5.000 1.034 1.187 1.111 0.621 2.199 
 
 
Figure 4.  Standard curve of known BSA standard concentrations to determine unknown 
concentration of hemoglobin-HSA mixture sample. 





































A standard curve equation was determined based on the known concentrations of the 
BSA standard, y = 0.284x – 0.0041 where y is the net absorbance and x is the 
concentration. Net absorbance values for the five diluted samples were recorded.  Using 
the standard curve equation, concentrations of each sample were determined.  
Concentrations of the undiluted supernatant sample (sample volume = 5.0 µl) were used 
when determining the amount of sample to add to downstream protein digestion testing.  
The concentration of the 271 blood supernatant sample used for protein digestion testing 
was 1.717 µg/µl.  The concentrations of the hemoglobin-HSA samples used for protein 
digestion testing was either 3.128 µg/µl or 2.199 µg/µl. 
Agilent Bioanalyzer Assay Familiarization  
 Based on manufacturer specifications, the Agilent Protein 80 kit has a sizing 
range of 5-80 kDa and is more sensitive for qualitative testing of samples concentrated 
between 0.006 – 4.000 µg/µl than the Agilent Protein 230 kit.  For this reason, the 
Agilent Protein 230 kit was used for lab familiarization and the Agilent Protein 80 kit 
was used for any samples where protein digestion was performed.  Blood supernatant 
samples were run diluted and neat on the Agilent Protein 230 kit.  In figure 5 a gel image 
of neat and diluted blood supernatant samples is shown.  Based on band intensity, lanes 1 
through 6 qualitatively show a decrease in the amount of protein present in the blood 









Figure 5.  Gel image of a bioanalyzer run qualitatively showing the decrease in the 
concentration of protein present in blood samples.  Protein concentrations were measured 
in kilo-Daltons (kDa). 
 
PMSF time 0 establishment 
 A trial run of freshly prepared PMSF compared to older stock PMSF was 
performed to evaluate the quenching ability of fresh versus old PMSF as well as establish 
a “time 0” bioanalyzer run to compare samples where trypsin and PMSF were added.  
Figure 6 shows the comparison of trial runs between freshly made and old PMSF.  The 
multiple bands in all sample wells where PMSF was added after trypsin show that trypsin 
digestion began to immediately occur with the addition of trypsin.  After PMSF was 
added digestion stopped, however there would always be some digestion that occurred 








Figure 6.  Comparison of freshly made PMSF versus old PMSF to establish “time 0” for 
trypsin digestions. 
 
Based on band intensity the freshly made PMSF showed stronger band intensity at 
approximately 11.0 kDa compared to the old PMSF.  The old PMSF had stronger band 
intensity at approximately 5.0 kDa.  This indicates at time 0 more digestion occurred 
using old PMSF to quench the digestion as compared to freshly made PMSF.  The figure 
also shows that when no trypsin was added to samples no digestion occurred.  Table 11 
shows the different peak sizes seen at time 0 for fresh and old PMSF.  Electropherograms 
of each bioanalyzer run were used to compare the size of the digested protein for each 
sample (based on peak size in electropherogram, visualized as a band on the gel).  An 






peak ranges will be used to compare different digestion conditions where PMSF is used 
to quench the digestion after a specified amount of time.   
Table 11. Peak size of visible bands seen in time 0 comparison of freshly made versus old 
PMSF. 
  Peak Size (kDa) 
  Peak 1 Peak 2 Peak 3 Peak 4 Peak 5 Peak 6 
No Trypsin/No PMSF 1 11.5           
Fresh PMSF 1 5.1 5.5 5.9 6.3 8.1 10.1 
Fresh PMSF 2 5.3 6.1 6.7 8.9 11.1   
Fresh PMSF 3 5.0 5.3 5.7 6.1 7.2 9.1 
Fresh PMSF 4 5.2 5.9 6.4 8.3 10.3   
Old PMSF 1 5.1 5.9 6.3 7.7 9.9   
Old PMSF 2 5.4 6.2 7.1 9.5 11.7   
No Trypsin/Fresh PMSF 1 11.7           
No Trypsin/Fresh PMSF 2 11.7           
No Trypsin/No PMSF 2 11.8           
 
Traditional protein digestion at different temperatures 
 Comparison of varying digestion temperatures using the traditional digestion 
method were tested to determine digestion efficiency.  These digestions were used as a 
baseline of the traditional digestion to compare to microwave digestion methods under 
similar conditions.  Temperature conditions tested were 45°C, 55°C and 65°C.  
Incubation was performed on a table top incubator for 15-minutes.  A positive control 
which doubled as the current traditional method comparison was run at 37°C on a 
separate table top incubator.  Negative controls were processed with the sample and all 
reagents excluding trypsin.  Figure 7 shows the bioanalyzer results for the 45°C and 55°C 
trials.  Figure 8 shows the results for the 65°C trial.  Each bioanalyzer gel image 
indicates, as incubation temperature increased, digestion efficiency decreased.  Digestion 
efficiency was determined by the number of intermediate digestion products present as 
well as the intensity of the intermediate digestion product bands.  More intermediate 






digests to the traditional incubation digest indicates at 45°C, digestion was similar to but 
not as efficient as the digestion at 37°C.  Band intensity of the second larger fragment 
peak was stronger for samples incubated at 45°C than it was at 37°C.  This indicated a 
higher concentration of intermediate digestion product at that fragment size for the 45°C 
samples and slightly less efficient digestion.  Multiple peak bands were seen in the 55°C 
run.  The bands seen in this run are similar to the ones seen for the PMSF time 0 trials 
indicating some digestion occurred but the digestion was not very efficient.  The 
strongest band present at the 55°C incubation was the largest peak (12.9 kDa) indicating 
minimal digestion.  Multiple bands were present in the 65°C run however the most 
intense band by far was the largest band (12.9 kDa).  The intensity of this band was most 
similar to the negative control indicating the least effective digestion at this temperature.  
Sample 6 (lane 4 on the gel image) had a large dip below the baseline in the 
electropherogram due to an error during the run.  The electropherogram can be referenced 
in the appendix (Figure 19).  Results and peak sizes from this sample will not be as 
accurate due this anomaly however it can still be clearly seen that this sample also 






       
Figure 7.  Traditional protein digestion on incubator at 45°C and 55°C compared to 
















Table 12 lists the peak bands seen at each temperature condition.  More peak bands 
indicate less efficient digestion for those temperatures.  Temperatures of 37°C and 45°C 
where the undigested sample peak band (12.9 kDa) is completely gone indicate a more 
efficient digestion. 
Table 12.  Peak sizes seen for each temperature digestion condition. 
  Peak Size (kDa)   
  Peak 1 Peak 2 Peak 3 Peak 4 Peak 5 Peak 6 Peak 7 
Positive Control 1, 37°C 5.3 6.7           
Positive Control 2, 37°C 5.8 7.9           
Sample 1, 45°C 5.8 7.8           
Sample 2, 45°C 5.8 8           
Negative Control 1, 45°C 12.8             
Negative Control 2, 45°C 12.8             
Sample 3, 55°C 5.7 6.1 6.6 7.9 9.2 11.1 12.9 
Sample 4, 55°C 6.1 6.6 7.9 9.3 11.2 12.9   
Negative Control 3, 55°C 12.9             
Negative Control 4, 55°C 12.9             
Positive Control 3, 37°C 5 6.2           
Positive Control 4, 37°C 5.7 7.6           
Sample 5, 65°C 6.1 6.5 7.9 9.3 11.2 12.9   
Sample 6, 65°C 4.9 5.5 6.3 7.8 10     
Negative Control 5, 65°C 12.9             
Negative Control 6, 65°C 12.8             
Traditional sample protein digestion at different times 
 Blood samples and hemoglobin-human serum albumin (HSA) mixture samples 
were digested following traditional protein digestion procedures on an incubator at 37°C.  
Gel images were captured on the Agilent 2100 Bioanalyzer using the Agilent Protein 80 
kit.  Digestion times of 15-minutes, 30-minutes, 1-hour, 2-hours and overnight were 
compared.  Figures 9 and 10 show the gel image for comparison of each time trial for 
blood and hemoglobin-HSA samples.  Gel images for individual runs of 30-minutes, 1-






(Figures 20-27).  The longer the digestion time the less intense the protein band.  Color 
intensity of the bands on the gel image indicate the concentration of protein present at 
that size.  Higher intensity bands indicate a higher concentration of protein at that size 
and lower intensity bands indicate a lower concentration of protein.  For the blood sample 
a single band at approximately 12.5 kilo-Daltons (kDa) is visible in all lanes where no 
trypsin digestion was performed.  This band likely represents the protein hemoglobin 
found in blood samples.  Lanes 2 and 8 show the time 0 comparison when trypsin was 
added to the sample followed immediately by PMSF to quench the digestion.  It can be 
seen that some digestion did occur at time 0.  In all lanes where trypsin digestion took 
place the 12.5 kDa band is no longer present and there is an intermediate band at 
approximately 5.5 kDa, showing digestion of the larger protein into smaller fragments.  
The band intensity at the 5.5 kDa band is similar for the 15-minute, 1-hour and 2-hour 
runs.  The band is significantly more intense for the 30-minute run but less intense for the 
overnight run.  It can be seen that generally the intensity of the 5.5 kDa band decreased 
over time.  The increase in band intensity at approximately 3.5 kDa also suggests some of 
the protein from the sample was digested further to the smaller 3.5 kDa fragments.  This 







Figure 9. Comparison of traditional trypsin protein digestion of blood sample for 15-
minutes, 30-minutes, 1-hour, 2-hours and overnight.   
For the hemoglobin-HSA mixture samples where no trypsin digestion took place, two 
main bands were seen, one at approximately 63.3 kDa and one at approximately 12.4 
kDa.  The 63.3 kDa band represents the human serum albumin protein and the 12.4 kDa 
band represents the hemoglobin protein.  Lane 2 shows the time 0 comparison when 
trypsin was added to the sample followed immediately by PMSF to quench the digestion.  
It can be seen that some digestion did occur at time 0.  In all lanes where trypsin 
digestion took place the 63.3 kDa and 12.4 kDa bands are no longer present and are 
replaced by bands between 4.1 kDa and 7.6 kDa depending on the sample.  These bands 






The 30-minute, 1-hour and 2-hour digestion samples show bands at 4.9 and 7.6 kDa, 4.9 
and 7.5 kDa, and 4.1 and 5.9 kDa respectively.  The 15-minute digestion shows a single 
band at 5.8 kDa however this is not believed to be a true representation of the digestion.  
The overnight digest shows a nearly non-existent band at 4.1 kDa.  None of the samples 
showed any bands near the 63.3 kDa range.  Treating the 15-minute digestion sample as 
an outlier, based on band intensity, it appears that as digestion time increased with these 
samples, overall protein digestion increased.  Based on the change in intensity of the band 
at 3.5 kDa it suggests further digested protein fragments at that smaller intermediate 
digestion product size were also seen in these samples. 
Figure 10. Comparison of traditional trypsin protein digestion of hemoglobin-HSA 






Comparison of microwave incubation at different temperatures and times 
 Microwave assisted protein digestion was compared at different microwave 
incubation temperatures and times.  Microwave temperature samples were compared to 
positive control samples digested on a table top incubator at 37°C.  Temperature 
digestions of 37°C, 45°C, 55°C and 65°C were performed for 15-minutes.  Microwave 
digestions included a 3-minute ramp up to temperature and a 12-minute digestion while 
positive controls were on an incubator for the full 15-minutes.  Figures 11 through 14 are 
the bioanalyzer runs for microwave digestions at 37°C, 45°C, 55°C and 65°C 
respectively.  The 37°C run showed the most comparable results to the 37°C positive 
control.  Both samples had complete digestion of the 12.7 kDa sample protein.  Two 
smaller protein fragments between 7.8 kDa and 5.3 kDa were seen in both the microwave 
sample and positive control sample.  Band intensity was also stronger for these samples 
around the 5.3 kDa peak and the less intense band around 7.8 kDa.  Both 37°C 
microwave samples and positive controls showed increased band intensity at the 3.5 kDa 
bioanalyzer system peak as well.  These peaks and intensities all indicate similar 
digestion efficiency between the microwave and 37°C and traditional incubator digestion 







Figure 11.  Comparison of the microwave incubation at 37°C versus traditional incubator 








Figure 12.  Comparison of the microwave incubation at 45°C versus traditional incubator 








Figure 13.  Comparison of the microwave incubation at 55°C versus traditional incubator 








Figure 14.  Comparison of the microwave incubation at 65°C versus traditional incubator 







Microwave digestions at 45°C, 55°C and 65°C all had more than two peak bands present 
between approximately 5.7 kDa and 12.9 kDa.  Multiple bands (more than two) for each 
of these temperature conditions and the presence of the 12.9 kDa band indicate a less 
efficient protein digestion at the higher temperatures.  Intensity of the 3.5 kDa band was 
also less intense than seen in the 37°C positive control or 37°C microwave sample 
providing more evidence to a less efficient digestion.  Table 13 shows all of the peak 
sizes seen for each temperature digestion condition.  For the 65°C run trypsin was 
accidentally added to all negative controls so there is no standard to compare where 
trypsin was not added for that run.  However, it should be noted that the less efficient 
digestion at 65°C is still indicated by the multiple peak bands seen.  Based on these 






Table 13. Peak band sizes seen for microwave digestions of 37°C, 45°C, 55°C and 65°C. 
    
37°C 45°C 55°C 65°C 
5.3 5.7 6.1 6.1





5.4 5.8 6.2 6.1





5.7 5.7 6.3 5.8





5.7 5.6 6.3 5.5
7.8
5.7 5.4 6.0 5.7
7.7 6.9 8.2
9.8




























Neg. Control Frz. 2
Pos. Control 2
Neg. Control MCRW 1
Neg. Control MCRW 2






Microwave digestion times of 15-minutes, 30-minutes, 1-hour and 2-hours were 
compared.  Digestions were performed at 37°C based on the results of the previous 
temperature test.  Microwave digestion times of 5-minutes and 10-minutes were also 
performed; see appendix (Figures 28 and 29).  It was determined these digestion times 
were two short and were not considered to test ideal digestion time.  All microwave 
digestions included a 3-minute ramp up to temperature with the remaining time being 
used for the digestion (i.e. 30-minute digest = 3-minute ramp, 27-minute digest).  Figure 
15 shows the 15-minute and 1-hour microwave digestions compared to the digestions of 
the same time on a table top incubator.  Figure 16 shows the 30-minute and 2-hour 
microwave digestions compared to the digestions of the same time on a table top 
incubator.  A sample was digested overnight following the traditional procedure and run 







Figure 15.  15-minute and 1-hour microwave digestion compared to incubator digestion.  







Figure 16.  30-minute and 2-hour microwave digestion compared to incubator digestion.   
 
As can be seen in the above figures, all samples incubated in the microwave showed 
digestion of the 12.9 kDa band.  A single band at approximately 5.5 kDa was seen in each 
time trial indicating digestion of the 12.9 kDa band had occurred but not to completion.  
As the length of digestion increased from 15-minutes to 2-hours the intensity of the 5.5 
kDa band decreased.  This indicates as the sample digestion incubated longer more 
digestion occurred.  Comparison of the microwave samples to the sample incubated on 
the table top incubator showed similar band intensities at 5.5 kDa indicating the 
microwave and incubator had similar digestion efficiencies.  No peak band intensity of 
the overnight sample was seen at 5.5 kDa indicating complete digestion of the 12.9 kDa 






microwave showed comparable digestion to the incubator however complete digestion 
was not achieved as was seen in the overnight incubation. 
Comparison of buffers during microwave incubation 
 Three different buffers were compared to test the effect of each on protein 
digestion.  This was done in an attempt to conserve reagents when samples were not 
planned to be processed on a mass spectrometry instrument.  Samples that would 
typically be processed on a mass spectrometry instrument use 20 µl of 500mM TEAB 
buffer.  A 50mM dilution of 500mM TEAB buffer and 50mM ABC buffer were 
compared to the original 500mM TEAB buffer.  All protein samples tested came from 
blood sample 271 following the digestion protocol described in the Methods and 
Materials section.  Figure 17 is a gel image comparing the three buffers.  Samples in 
lanes 1, 4 and 7 were digested using the CEM MARS 6 microwave at 37°C for 15-
minutes.  Samples in lanes 2, 5 and 8 were used as positive controls to test the digestion 
on a traditional incubator at 37°C for 15-minutes.  Samples in lanes 3, 6 and 9 were used 
as negative controls, they were incubated at 37°C in the CEM MARS 6 microwave for 







Figure 17. Comparison of digestion efficiency of three different buffers in the MARS 6 
microwave and traditional incubator. 
 
As can be seen in figure 17 the 500mM and 50mM TEAB buffer appear to show better 
protein digestion efficiency after 15-minutes than the 50mM ABC buffer.  In the lanes 
with TEAB buffer, both the microwave and traditional incubator digestion showed the 
large protein band at approximately 12.5 kDa seen in each negative control is no longer 
present and an intermediate digestion product band at approximately 5.6 kDa is now 
present.  In the ABC buffer two distinct bands can be seen in the microwave and 
incubator lanes; one at approximately 5.9 kDa and one at approximately 8.5 kDa 
indicating the digestion was not as efficient as the TEAB buffer.  Table 14 below shows 







Table 14.  Peak size of digested and undigested samples. 






TEAB 500mM  5.4  
TEAB 500mM POS 5.6  
TEAB 500mM NEG 12.6  
TEAB 50mM  5.7  
TEAB 50mM POS 5.7  
TEAB 50mM NEG  12.5  
ABC 50mM  5.9 8.2 
ABC 50mM POS  6.0 8.5 
ABC 50mM NEG 12.6  
 
Based on the size of the peaks seen, all three buffers performed similarly.  The TEAB 
buffer at 500mM showed protein bands at 5.4 kDa (microwave) and 5.6 kDa (incubator) 
while the TEAB buffer at 50mM showed protein bands at 5.7 kDa for both the 
microwave and incubator.  The ABC buffer showed slightly larger protein bands at 5.9 
kDa (microwave) and 6.0 kDa (incubator) as well as a secondary band at 8.2 kDa 
(microwave) and 8.5 kDa (incubator).  The larger bands in the ABC buffer as well as the 
secondary band indicate the TEAB buffer at either concentration was slightly more 
efficient in aiding protein digestion than the ABC buffer.  This allowed for use of a 
diluted concentration of TEAB buffer for samples not being processed on the mass 








Bradford Protein Assay Sample Concentrations 
To familiarize with lab practice, the protein concentrations of blood samples were 
determined using the Bradford Protein Assay.  A range of known concentrations of 
bovine serum albumin (BSA) was prepared along with a range of dilutions of the 
unknown blood samples.  Fluorescence of the BSA dilutions was measured and a 
standard curve using the known concentrations was prepared.  Fluorescence of the 
unknown sample dilutions was then compared to the standard curve.  Concentrations 
were multiplied by the dilution factor obtained from sample preparation.  The average of 
these concentrations was determined and the concentration of each prepared sample was 
estimated.  Neat sample protein concentrations for blood were estimated by multiplying 
the prepared sample concentrations by the dilution factor prior to sample 
homogenization.  Neat blood protein concentrations were estimated to be 228.5 µg/µl.  
Expected sample concentrations of blood were approximately 150.0 µg/µl.  Variation 
between actual concentrations observed and expected concentrations can be attributed to 
sample preparation method in which large dilutions of each sample were made.  The 
Bradford Assay tests were performed to help familiarize with sample preparation, 
dilution and protein concentration so samples could properly be prepared for protein 
digestions.  These samples were not used during protein digestion. 
Blood samples and hemoglobin-HSA samples were prepared and concentrations 
of diluted samples were determined using the Bradford Protein Assay.  Two different sets 
of hemoglobin/HSA mixture samples were prepared.  Comparison to the standard curve 






while the hemoglobin-HSA mixture samples had an approximate concentration of 3.128 
µg/µl and 2.199 µg/µl.  These known concentrations were used to determine the volume 
of sample added for each protein digestion.  Total sample protein in a digestion was 
approximately 20 µg.  Two microliters of 0.5 µg/µl trypsin was added to each digestion 
so the protein to trypsin ratio was 20:1.  Protein to trypsin ratio was determined from 
previous testing for body fluid identification by mass spectrometry (Yang, Zhou, Deng, 
Prinz, & Siegel, 2013).  This protein to trypsin ratio appeared to show efficient digestion 
ability for the examined digestion parameters.  Protein digestion was visualized on the 
Agilent 2100 Bioanalyzer.  A gel image was generated based on electropherogram peaks 
observed after microfluidic gel electrophoresis (MiGE).  Protein samples were added to 
the microfluidic chip and, with the help of an electric current, passed through a small 
column.  The larger the protein size the longer it would take to pass through the column.  
In the column the protein sample binds to a fluorescent dye.  When the fluorescent bound 
protein sample nears the end of the column a laser excites the dye and a fluorescent signal 
is released.  This signal is recorded on an electropherogram.  The sizing ladder marks 
known protein sizes based on the time traveled through the column.  By comparing the 
sample to the ladder, the size of the sample protein is determined based on the time it 
took to pass through the column.  The amount of protein present in the sample is based on 
the intensity of the fluorescent signal released after the sample is excited with a laser.  
The intensity of the bands correlate to the peak height in the electropherogram.  The more 
protein in the sample, the more fluorescence the sample will give after laser excitation, 
the more intense the band on the gel, and the taller the peak in the electropherogram.  






on the electropherogram can be visualized in a gel image.  Figure 5 shows how the 
protein bands in neat and diluted blood samples are visualized on the gel image.  Based 
on band intensity, lanes 1 through 6 qualitatively show a decrease in the amount of 
protein present in the blood sample from 1.0 µg/µl to 0.2 µg/µl.  The decrease in intensity 
is expected because the amount of protein in the sample was decreased.   
PMSF time 0 establishment 
Phenylmethylsulfonyl fluoride (PMSF) was used to quench the trypsin digestion.  
This was done to stop any trypsin digestion from continuing after samples were removed 
from the incubation source.  This allowed for more accurate evaluation of the time and 
temperature trials in regards to how efficient protein digestion was for the conditions 
tested.  PMSF was chosen as the quenching mechanism for the trypsin digestion based on 
its high inhibitor activity.  Garcia-Carreno (1993) showed PMSF inhibited trypsin at 
96%, suggesting once samples were removed from the incubation step and PMSF added, 
minimal digestion would continue to take place.  A boiling method was also considered 
to quench digestion (Petritis, Qian, Camp II, & Smith, 2009), however this method 
involved liquid nitrogen freezing after boiling of the sample and seemed more difficult to 
perform.  Time 0 digestion was established by adding trypsin to the sample directly 
followed by PMSF so the PMSF would immediately stop the digestion.  Bioanalyzer 
results show that upon the addition of trypsin, even when PMSF is added to the sample 
first, some digestion still takes place.  This can be attributed to the fact that while PMSF 
does inhibit trypsin digestion, the inhibition is not complete.  The time 0 PMSF trial also 
compared the use of freshly made 10mM PMSF compared to week old stock 10mM 






Based on the intensity of the digestion bands seen in the bioanalyzer image, freshly made 
PMSF showed stronger ability to inhibit trypsin digestion than older stock PMSF.  For 
this reason, fresh PMSF was made each week to be used in trypsin digestion runs for that 
week.  Conceding that some digestion will still be visible after a quenching step is added, 
evaluation of protein digestion under different temperature and time conditions was 
compared to the time 0 digestions. 
Comparison of traditional incubation at different temperatures and times 
Different temperatures of the traditional trypsin digestion protocol were compared 
to establish a baseline as to how digestion at these temperatures would compare to 
digestion at the same temperatures in a microwave.  Temperatures that were tested under 
traditional incubation conditions included 37°C, 45°C, 55°C and 65°C.  A fifteen-minute 
incubation time was selected for the temperature evaluation because most literature using 
microwave assisted digestion suggested protein samples could be digested between a 
range of seconds to 1-hour.  Fifteen minutes was an average time within that range and 
established enough digestion to determine an ideal temperature for protein digestion.  It 
has also been seen that an initial rapid increase in temperature can increase protein 
digestion before it levels off (Collins & Leadbeater, 2007).  The increase was seen in the 
first 5 minutes so the 15-minute incubation time was able to cover this initial rapid 
digestion followed by extra time to digest the sample after leveling off.  After the ideal 
temperature was established, different time trials of the traditional method were tested for 
comparison to microwave assistance times.  Based on the temperatures evaluated, 37°C 
and 45°C appeared to show the most efficient protein digestion.  Samples tested at these 






expected hemoglobin band at 12.9 kDa was not present.  Samples tested at 55°C showed 
multiple (6-7) intermediate product bands between 5.7 and 12.9 kDa.  The strongest 
protein band was seen at 12.9 kDa which is the expected size for the hemoglobin protein 
suggesting minimal protein digestion at this temperature.  Samples tested at 65°C also 
showed multiple (5-6) intermediate product bands between 4.9 and 12.9 kDa.  Again, the 
strongest protein band present was the 12.9 kDa band, stronger than in the 55°C sample 
suggesting even less protein digestion at this temperature.  
Traditional protein digestion using trypsin was performed according to the 
methods described above in the methods section and different incubation times were 
compared.  Incubation times of 30-minutes, 1-hour, 2-hours and overnight were evaluated 
and were used to visually compare the amount of expected protein digestion during these 
times.  As was expected, the longer the incubation period the more protein digestion.  
This was confirmed by bioanalyzer runs for each trial.  Each digestion showed as the time 
increased for each trial the intensity of the digested protein band decreased.  For the 
overnight digest of the blood sample there was a faint band present suggesting near 
complete protein digestion.  Outside of the system peak at 3.5 kDa, there was no band 
present in the hemoglobin-HSA mixture sample.  Also consistent across all samples was 
an increase in intensity of the system peak at 3.5 kDa as the incubation time increased to 
two hours then a decrease for the overnight incubation.  This suggests a higher 
concentration of smaller protein fragments at the 3.5kDa size and that more protein 
digestion occurred as run time increased.  Protein digestion involves breaking the protein 
down ultimately into its smaller peptide components.  The peptide components are too 






as incubation time approached overnight suggest a decrease in protein fragments of this 
size because they were digested further into the smaller peptide components.   
Comparison of microwave incubation at different temperatures and times 
Microwave assisted protein digestion was compared at different microwave 
incubation temperatures and times.  The different temperatures tested included 37°C, 
45°C, 55°C and 65°C.  Microwave temperature incubation trials were performed for 15-
minutes with a 3-minute ramp up to temperature and a 12-minute digestion at 
temperature.  Results for the microwave incubation were compared to the results from the 
traditional incubation at the same temperatures.  Based on the number of intermediate 
digestion products present at each temperature, 37°C appeared to show the most efficient 
digestion when microwave assistance was used.  At 37°C only two intermediate digestion 
products were present, none of which were the original hemoglobin band.  When 
compared to the traditional digestion method at 37°C for the same amount of time the 
digestion patterns were similar between table top incubation and microwave assistance.  
All other temperature trials showed between five and six intermediate digestion product 
bands when digested with microwave assistance.  Samples with microwave assistance at 
55°C and 65°C showed similar intermediate digestion product suggesting inefficient 
digestion at these temperatures.  When compared to the traditional method, the digestion 
band pattern was similar for the 55°C and 65°C trials.  However, the intensity of the 
smaller intermediate bands for the microwave assistance were stronger than the bands 
seen in the traditional method.  Also, while the hemoglobin band was present in both trial 
methods, it was more intense in the traditional method than in the microwave assisted 






temperatures, microwave assistance did provide better digestion than the traditional 
method.  This could be attributed to the increased digestion efficiency from ramping up 
to temperature, as suggested by Collins et al. (2007).  Traditional digestion at 45°C 
showed better digestion than microwave assistance at 45°C.  The traditional digestion 
showed only two intermediate digestion products while the microwave assistance showed 
5 intermediate digestion products including the original hemoglobin band.  This suggests 
that traditional incubation at 45°C is more efficient at protein digestion than microwave 
assistance at the same temperature.   
Microwave assisted protein digestion was tested at different times and compared 
to traditional protein digestion for the same amount of time.  Digestions were tested for 
15-minutes, 30-minutes, 1-hour and 2-hours.  Overnight time trials were performed using 
the traditional method to compare microwave assisted digestion to traditional overnight 
complete digestion.  Digestions were performed at 37°C since this temperature was found 
to be the ideal microwave assisted temperature.  Each digestion time showed a single 
intermediate digest product band at approximately 5.5 kDa.  As digest time increased the 
intensity of the 5.5 kDa intermediate band decreased suggesting increased protein 
digestion as more time passed.  The size of the intermediate protein fragment and the 
intensity of the band was similar between microwave assisted and traditional incubator 
digestions.  None of the digested samples showed the 12.9 kDa hemoglobin band 
suggesting that the larger protein molecule would be digested into smaller fragments in as 
little as 15-minutes in both microwave assisted and incubator digestions.  The 2-hour 
digestion showed the most complete protein digestion when compared to the overnight 






perform the digestion, the more the protein sample would be digested.  These results 
indicate similar results were achieved with microwave assisted digestion when compared 
to traditional digestion on an incubator.  Further research could be conducted to test if 
more peptides were generated by one method over the other for the shortened digestion 
periods and if there were enough peptides from the shorter digests to identify body fluids. 
Comparison of buffers during microwave incubation 
While preparing samples and testing different incubation conditions a need to 
conserve reagents was realized.  As with any research being conducted in a lab, one of 
the goals should be to determine if the new procedure being tested will be cost effective.  
In an attempt to make this procedure more cost effective, different buffer solutions were 
tested.  This was done to conserve reagents for samples that were not going to be 
processed using mass spectrometry but where similar protein digestion results were 
desired.  The normal buffer used for the protein digestion is 500mM of 
triethylammonium bicarbonate (TEAB).  To conserve this reagent a 1:10 dilution to 
50mM TEAB was made.  The 500mM and 50mM TEAB were then compared to 50mM 
ammonium bicarbonate (ABC) to test digestion efficiency between the three buffers.  
Other than the different buffers, all other reagents and procedural steps were kept the 
same.  Microwave incubation was performed at 37°C for 15-minutes.  Samples that were 
resuspended in TEAB buffer (500mM or 50mM) showed a single intermediate band at 
approximately 5.6 kDa while the ABC buffer (50mM) had two intermediate bands at 6.0 
and 8.5 kDa.  Based on this data all buffers showed that protein was able to be digested 
when resuspended in them however the TEAB allowed for more protein digestion and 






was no major difference seen between the 500mM TEAB buffer and the 50mM TEAB 
buffer suggesting that a diluted 50mM TEAB buffer could be used when resuspending 
protein samples for digestion without a loss of digestion efficiency and with a possible 
increase in cost savings.   
Future considerations 
This research suggests that microwave assistance may be used to digest protein 
samples, however further research needs to be conducted to demonstrate increased 
digestion efficiency while decreasing incubation time.  In 2018, Dr. Donald Siegel of the 
New York City OCME published a technical report for a National Institute of Justice 
grant which, in part, expanded on the research conducted here regarding microwave 
digestion of proteins.  In this report he was able to show a direct improvement in protein 
digestion efficiency through the use of microwave assistance.  He also found increased 
microwave power levels show similar digestion results to lower power levels and the 
addition of organic solvents has the potential to increase digestion efficiency.   
Siegel (2018) showed the effects of microwaves on trypsin digestion provide a 
nearly 50% increase in digestion efficiency when compared to trypsin digestion in an 
incubator.  Using electropherograms of bioanalyzer results, the area under the curve of 
undigested protein was measured and it was shown that in cases of microwave assisted 
digestion, there was approximately 50% more undigested protein in samples digested in 
an incubator versus samples digested in a microwave for the same amount of time 
(Siegel, 2018).  This finding expands on the research found in this thesis and strongly 






addition, an increase in the microwave power level was tested.  Most common 
microwaves run between 600 and 1200 watts and some research has been conducted with 
both a scientific microwave and conventional microwave (Lin, Wu, Sun, Sun, & Ho, 
2005).  Similar to the research reported in this thesis, Siegel processed most of his 
samples using 50 watts of power for the microwave.  In his technical report a test was 
performed where the microwave power level was increased to 850 watts and compared to 
the digestions performed at 50 watts.  Based on his results, Siegel found that the increase 
in microwave power showed similar digestion efficiency between 50 watts and 850 watts.  
Siegel (2018) also introduced organic solvents to his digestions to see what effect 
these would have on digestions, both with and without microwave assistance.  Research 
has shown different solvent systems have been used and have shown efficient digestion 
with the traditional method (Russell & Park, 2001).  Lin et al. (2005) also found the use 
of different organic solvent systems can increase digestion efficiency when combined 
with microwave irradiation.  Organic solvents can work as a denaturant to help unfold the 
target protein and increase digestion efficiency.  Addition of an organic solvent in the 
digestion process can provide another means to increase digestion efficiency while 
decreasing digestion time.  Five different organic solvents were tested at the OCME; 
acetone, acetonitrile, dimethyl sulfoxide, isopropanol and methanol.  Following the same 
comparison of area under the curve of undigested protein, Siegel found the addition of 
organics showed an increase in digestion efficiency in all cases without microwave 
assistance.  Methanol and dimethyl sulfoxide saw approximately a 12.5% increase in 
digestion while acetone, acetonitrile and isopropanol saw approximately a 25% increase.  






saw an increase in digestion efficiency of approximately 34%.  Methanol did not show a 
significant increase in digestion efficiency with microwave assistance.  Based on these 
organic solvent results, Siegel (2018) found results similar to near overnight digestion of 
protein samples can be achieved with a 20:1 (µg/µg) protein to trypsin ratio with 
microwave assistance at 37°C for 30 minutes and 10% isopropanol. 
Future research should include mass spectrometry runs of the sample times tested 
and the peptide spectrums should be compared to that of an overnight digestion.  This 
would provide a more accurate understanding of how much digestion is occurring 
through microwave irradiation alone.  This may also provide information regarding the 
peptide sequence and if a 15-minute digestion is long enough to provide adequate peptide 
sequence for body fluid identification based on previously established markers.  This type 
of research could also be important in determining how much protein sample is needed to 
produce enough peptide sequence for analysis.  Identifying a lower limit for sample 
protein input into the assay can directly affect how samples will be processed in a 
laboratory.  Research into enzymatic digestion has suggested replacing in solution trypsin 
with immobilized trypsin for protein digestion (Lin, et al., 2008, B).  This type of 
digestion with microwave assistance was found to have high digestion efficiency in as 
little as 15 seconds and could help reduce overall digestion times.  Only blood 
supernatant samples and samples prepared from powdered hemoglobin and human serum 
albumin were used in this research.  Other body fluid types that have previously been 
tested and have marker profiles would also need to be tested under microwave irradiation 
to ensure the same profiles can be obtained.  If similar results can be obtained for the 






procedure.  Lastly testing could be performed to try to automate the system to increase 
sample output while decreasing costs.  The ability to use a diluted sample of TEAB 
buffer can provide 10 times as much buffer reagent for use.  This extra reagent could be 
used on a plated system to increase the number of samples that can be prepared at one 
time.  Microwave digestion of the sample in a plate would need to be tested to see if this 
could be beneficial.     
The research conducted found that microwave assistance in protein digestion of 
blood supernatant samples and hemoglobin-human serum albumin mixture samples is 
best performed when the microwave temperature is set to 37°C.  This digestion 
temperature was found to be most comparable to traditional digestion on a table top 
incubator.  Microwave assisted digestion was tested at time trials of 15-minutes, 30-
minutes, 1-hour and 2-hours and was compared to traditional digestion at those same 
times as well as overnight digestion.  The microwave assistance was found to produce 
similar results to traditional digestion on a table top incubator for the tested times.  
Longer digestion times did show better digestion, consistent with the table top incubator.  
None of the digestion times showed the near complete digestion seen during overnight 
incubation.  In testing reagent use for cost savings, it was found that a dilution of the 
500mM TEAB buffer to 50mM TEAB can produce similar protein digestion results and 
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Figure 18. Example electropherogram.  This electropherogram was taken from the 
traditional incubation run at 55°C for 15 minutes.  Each distinct peak in the run is 
represented by a band on the gel image. 
 
 
Figure 19. Electropherogram representing traditional incubation at 65°C for 15 minutes.  
A large dip below baseline can be seen between peaks 2.3 and 3.1 indicating an error in 





























































































Preparation of gel-dye mix and de-staining solution for the Agilent Protein 230 Kit  
 
The reagents were removed from 4°C storage and allowed to sit at room 
temperature for 30 minutes to equilibrate.  Twenty-five microliters of Protein 230 dye 
concentrate were added to 650 µl of a stock tube of Protein 230 gel matrix creating a gel-
dye mix.  The tube was vortexed using a vortex mixer (Fisher Scientific, Waltham, USA) 
for 10 seconds and spun down for 15 seconds.  The entire gel-dye mix was transferred to 
the top receptacle of a spin filter tube.  The tube was labeled with “Protein 230 gel-dye 
mix” and the date it was prepared.  To prepare the de-staining solution, a separate tube of 
Protein 230 gel matrix was obtained and all 650 µl was transferred to the top receptacle 
of a new spin filter tube.  This tube was labeled with “Protein 230 DS” and the date it was 
prepared.  Both spin filters were placed in a 5415D Eppendorf Microcentrifuge 
(Hamburg, Germany) and spun at room temperature for 15 minutes at 2500 x g ± 20%.  
The gel-dye mix had an expiration date four weeks after the preparation date, the de-
staining solution was good through the use of the kit. 
Preparation of gel-dye mix and de-staining solution for the Agilent Protein 80 Kit 
The reagents were removed from 4°C storage and allowed to sit at room 
temperature for 30 minutes to equilibrate.  Two tubes of Protein 80 gel matrix were 
obtained.  All 650 µl of each tube was added to the top receptacle of two separate spin 
filter tubes.  One spin filter tube was labeled with “Protein 80 gel-dye mix” and the date 
prepared while the other was labeled with “Protein 80 DS” and the date prepared.  Both 
spin filters were placed in a 5415D Eppendorf Microcentrifuge (Hamburg, Germany) and 
spun at room temperature for 15 minutes at 2500 x g ± 20%.  To the tube labeled “Protein 






for 10-20 seconds until a uniform color was obtained.  The gel-dye mix had an expiration 
date four weeks after the preparation date, the de-staining solution was good through the 
use of the kit. 
Preparation of Denaturing Solution, Samples and Ladder 
For both the Agilent Protein 80 and Agilent Protein 230 kits, the same preparation 
steps for the denaturing solution, samples and ladder were taken.  A stock of 1M 
dithiothreitol (DTT) was made by combining 0.154 g of DTT (Sigma Aldrich, St. Louis, 
USA) in 1 mL of ddH2O.  Aliquots of 100 µl were transferred to 1.5 mL tubes and each 
tube was labeled with “DTT” and the preparation date.  These tubes were stored at -20°C.  
An aliquot of DTT was thawed and 7 µl of the DTT solution was mixed with 200 µl of 
sample buffer from the appropriate Agilent Protein kit to create the denaturing solution.  
The denaturing solution was stored at 4°C and would expire two weeks after the 
preparation date.  To start sample and ladder preparation the denaturing solution and the 
proper kit ladder were allowed to sit out for 30 minutes at room temperature to 
equilibrate.  Samples, ladder and denaturing solution were vortexed.  In a 0.5 mL tube 4 
µl of sample was combined with 2 µl of denaturing solution.  Tubes were vortexed well 
and the solution was spun to the bottom of the tube.  In a separate 0.5 mL tube 6 µl of the 
appropriate kit ladder with no denaturing solution was added.  The 0.5 mL tube 
containing sample or ladder was placed on a heat block (Eppendorf Thermomixer, 
Hamburg, Germany) and the samples were heat denatured at 95-100°C for 5 minutes.  
The tubes were allowed to cool for 10 seconds then spun them for 15 seconds to pull the 
sample volume to the bottom of the tube.  To each sample or ladder tube 84 µl of ddH2O 






Preparing the chip for the Agilent Protein 230 Kit 
Figure 30 below shows the placement of gel-dye and de-staining solution for 
preparing the Agilent Protein 230 chip.  The chip is labeled with which solution is to be 
added to each well.  Twelve microliters of gel-dye were added to the upper right most 
well and the chip was placed in the priming station.  The plunger was depressed on the 
syringe and held in place with a clip for 60 seconds.  After 60 seconds the plunger was 
released, the chip was removed and any remaining gel-dye was removed from the well.  
To each well labeled to receive gel-dye, 12 µl of gel dye were added (four wells).  To the 
bottom right most well 12 µl of de-staining solution were added.   
 
    
Figure 30: Diagram of placement of gel-dye and de-staining solution on the microfluidic 
chip for the Agilent Protein 230 Kit (Agilent Technologies, Inc., 2011).  
Preparing the chip for the Agilent Protein 80 Kit 
Figure 31 below shows the placement of gel-dye and de-staining solution for 
preparing the Agilent Protein 80 chip.  The chip is labeled with which solution is to be 
added to each well.  Twelve microliters of gel-dye were added to the upper right most 
well and the chip is placed in the priming station.  The plunger is depressed on the 
syringe and held with a clip for 60 seconds.  After 60 seconds the plunger was released 






gel dye were added (three wells).  To the bottom right most well 12 µl of de-staining 
solution were added.   
    
Figure 31: Diagram of placement of gel-dye and de-staining solution on the microfluidic 
chip for the Agilent Protein 80 Kit (Agilent Technologies, Inc., 2011).  
Loading the sample and ladder and running the assay 
 Figure 32 below shows the placement of all samples and ladder on the chip.  A 
single chip is capable of running up to 10 samples and 1 ladder per chip.  To each sample 
well 6 µl of sample was added.  To the ladder well 6 µl of ladder was added. 
 
Figure 32: Diagram of placement of samples and ladder on the microfluidic chip for both 
the Agilent Protein 80 and Protein 230 Kits (Agilent Technologies, Inc., 2011).  
After all samples and ladder were loaded onto the chip, the chip was placed on the 
Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, USA).  Using the 
bioanalyzer software, the assay being performed was selected, Protein 230 Series II or 
Protein 80 Series II.  A simple run name, using the date of the run followed by the 
number run of the day, was created to save the run data.  Once the assay and file name 
were selected the user pressed start on the instrument tab and the run was started.  After 






ddH2O were added to a well on the cleaning chip and the chip was placed on the 
instrument for 10 seconds to clean the electrodes.   
 
